| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Activity of megestrol acetate in postmenopausal women with advanced breast cancer after nonsteroidal aromatase inhibitor failure: a phase II trial †
|
Bines, J.
|
|
|
25 |
4 |
p. 831-836
|
artikel
|
| 2 |
Adverse event management in patients with advanced cancer receiving oral everolimus: focus on breast cancer
|
Aapro, M.
|
|
|
25 |
4 |
p. 763-773
|
artikel
|
| 3 |
Agreement between HADS classifications and single-item screening questions for anxiety and depression: a cross-sectional survey of cancer patients
|
Mackenzie, L.J.
|
|
|
25 |
4 |
p. 889-895
|
artikel
|
| 4 |
A randomized controlled phase II trial of a novel composition of paclitaxel embedded into neutral and cationic lipids targeting tumor endothelial cells in advanced triple-negative breast cancer (TNBC)
|
Awada, A.
|
|
|
25 |
4 |
p. 824-831
|
artikel
|
| 5 |
Are male gender and non-adenocarcinoma histology valid prognostic factors for breast cancer?
|
Eren, O.O.
|
|
|
25 |
4 |
p. 911
|
artikel
|
| 6 |
A systematic review of the characteristics associated with recall rates, detection rates and positive predictive values of computed tomography screening for lung cancer
|
Seigneurin, A.
|
|
|
25 |
4 |
p. 781-791
|
artikel
|
| 7 |
Atopic conditions and brain tumor risk in children and adolescents—an international case–control study (CEFALO)
|
Shu, X.
|
|
|
25 |
4 |
p. 902-908
|
artikel
|
| 8 |
Bone mineral density screening should be routine in lymphoma patients
|
Thompson, M.A.
|
|
|
25 |
4 |
p. 913-914
|
artikel
|
| 9 |
Demystifying the role of tumor HPV status in recurrent and/or metastatic squamous cell carcinoma of the head and neck
|
Spreafico, A.
|
|
|
25 |
4 |
p. 760-762
|
artikel
|
| 10 |
Do quality of life or physical function at diagnosis predict short-term outcomes during intensive chemotherapy in AML?
|
Timilshina, N.
|
|
|
25 |
4 |
p. 883-888
|
artikel
|
| 11 |
Editorial board
|
|
|
|
25 |
4 |
p. ii-iii
|
artikel
|
| 12 |
EMVI-positive stage II rectal cancer has similar clinical outcomes as stage III disease following pre-operative chemoradiotherapy
|
Chand, M.
|
|
|
25 |
4 |
p. 858-863
|
artikel
|
| 13 |
Factors affecting surgical management following neoadjuvant therapy in patients with primary HER2-positive breast cancer: results from the NeoALTTO phase III trial
|
Criscitiello, C.
|
|
|
25 |
4 |
p. 910-911
|
artikel
|
| 14 |
Fracture incidence after 3 years of aromatase inhibitor therapy
|
Bouvard, B.
|
|
|
25 |
4 |
p. 843-847
|
artikel
|
| 15 |
Getting tissue out of harm's way
|
Hornby, C.J.
|
|
|
25 |
4 |
p. 915
|
artikel
|
| 16 |
High concordance of protein (by IHC), gene (by FISH; HER2 only), and microarray readout (by TargetPrint) of ER, PgR, and HER2: results from the EORTC 10041/BIG 03-04 MINDACT trial
|
Viale, G.
|
|
|
25 |
4 |
p. 816-823
|
artikel
|
| 17 |
Histologic subtypes of breast cancer following radiotherapy for Hodgkin lymphoma
|
Horst, K.C.
|
|
|
25 |
4 |
p. 848-851
|
artikel
|
| 18 |
How can communication by oncologists enhance patients' trust? An experimental study
|
Hillen, M.A.
|
|
|
25 |
4 |
p. 896-901
|
artikel
|
| 19 |
Human epidermal growth receptor-2 overexpressing early operable primary breast cancers in older (≥70 years) women: biology and clinical outcome in comparison with younger (<70 years) patients
|
Syed, B.M.
|
|
|
25 |
4 |
p. 837-842
|
artikel
|
| 20 |
Impact of tumor HPV status on outcome in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck receiving chemotherapy with or without cetuximab: retrospective analysis of the phase III EXTREME trial
|
Vermorken, J.B.
|
|
|
25 |
4 |
p. 801-807
|
artikel
|
| 21 |
Incidence and time course of everolimus-related adverse events in postmenopausal women with hormone receptor-positive advanced breast cancer: insights from BOLERO-2
|
Rugo, H.S.
|
|
|
25 |
4 |
p. 808-815
|
artikel
|
| 22 |
Lapatinib concentration in cerebrospinal fluid in two patients with HER2-positive metastatic breast cancer and brain metastases
|
Gori, S.
|
|
|
25 |
4 |
p. 912-913
|
artikel
|
| 23 |
Letter to the editor on ‘Factors associated with surgical management following neoadjuvant therapy in patients with primary HER2-positive breast cancer: results from the NeoALTTO phase III trial’
|
Barry, P.A.
|
|
|
25 |
4 |
p. 909-910
|
artikel
|
| 24 |
Next-generation sequencing identifies germline MRE11A variants as markers of radiotherapy outcomes in muscle-invasive bladder cancer
|
Teo, M.T.W.
|
|
|
25 |
4 |
p. 877-883
|
artikel
|
| 25 |
Perioperative systemic chemotherapy in peritoneal carcinomatosis of lymph node positive colorectal cancer treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
|
Kuijpers, A.M.
|
|
|
25 |
4 |
p. 864-869
|
artikel
|
| 26 |
Phase II study of treatment of advanced ovarian cancer with folate-receptor-targeted therapeutic (vintafolide) and companion SPECT-based imaging agent (99mTc-etarfolatide) †
|
Morris, R.T.
|
|
|
25 |
4 |
p. 852-858
|
artikel
|
| 27 |
Present and future breast cancer management—bench to bedside and back: a positioning paper of academia, regulatory authorities and pharmaceutical industry
|
Bartsch, R.
|
|
|
25 |
4 |
p. 773-780
|
artikel
|
| 28 |
Rare cancers: work in progress in Europe
|
Casali, P.G.
|
|
|
25 |
4 |
p. 914
|
artikel
|
| 29 |
Reply to the letter to the editor ‘Are male gender and nonadenocarcinoma histology valid prognostic factors for breast cancer?’ by Eren et al.
|
de Vin, T.
|
|
|
25 |
4 |
p. 911-912
|
artikel
|
| 30 |
Reproducible, innovative, global and balanced: the pillars for manuscript acceptance at Annals of Oncology
|
Andre, F.
|
|
|
25 |
4 |
p. 759-760
|
artikel
|
| 31 |
Short leukocyte telomere length predicts poor prognosis and indicates altered immune functions in colorectal cancer patients
|
Chen, Y.
|
|
|
25 |
4 |
p. 869-876
|
artikel
|
| 32 |
Sleep disturbance in adults with cancer: a systematic review of evidence for best practices in assessment and management for clinical practice
|
Howell, D.
|
|
|
25 |
4 |
p. 791-800
|
artikel
|
| 33 |
Table of Contents
|
|
|
|
25 |
4 |
p. iv-vi
|
artikel
|
| 34 |
The current and future role of the medical oncologist in the professional care for cancer patients: a position paper by the European Society for Medical Oncology (ESMO)
|
|
|
|
25 |
4 |
p. 916
|
artikel
|
Tijdschrift beschrijving